Algert Global’s Boston Scientific BSX Stock Holding History

Algert Global’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,156	Closed	-$386K	–	1268
2026 Q1	$386K	Buy	6,156 +220	+4%	+$17.6K	0.01%	994
2025 Q4	$566K	Buy	+5,936	New	+$582K	0.01%	932
2025 Q3	–	Sell	-13,086	Closed	-$1.41M	–	1148
2025 Q2	$1.41M	Buy	13,086 +11,086	+554%	+$1.12M	0.03%	731
2025 Q1	$202K	Sell	2,000 -1,330	-40%	-$134K	0.01%	1086
2024 Q4	$297K	Buy	+3,330	New	+$293K	0.01%	992
2017 Q1	–	Sell	-69,547	Closed	-$1.5M	–	319
2016 Q4	$1.5M	Buy	69,547 +19,403	+39%	+$423K	0.43%	81
2016 Q3	$1.19M	Buy	+50,144	New	+$1.2M	0.35%	108
2014 Q1	–	Sell	-142,830	Closed	-$1.72M	–	321
2013 Q4	$1.72M	Sell	142,830 -380	-0.3%	-$4.49K	0.46%	75
2013 Q3	$1.68M	Sell	143,210 -323,200	-69%	-$3.5M	0.48%	66
2013 Q2	$4.32M	Buy	+466,410	New	+$3.96M	1.34%	4

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Algert Global's BSX Position: Q2 2026 in Review

Algert Global sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,156 shares — an estimated $386K sold.

Algert Global first reported a position in BSX in Q2 2013 and held it in 10 quarters. The position peaked at $4.32M in Q2 2013. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Algert Global reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Algert Global sold 6,156 Boston Scientific shares in Q2 2026, an estimated $386K.
Algert Global first reported a position in Boston Scientific in Q2 2013 and held it in 10 quarters.
Algert Global's Boston Scientific position peaked at $4.32M in Q2 2013.
1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.